References

Attachment 7

References

Medical Monitoring Project

0920-0740

Attachment 7

References

1. Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis 2007;44(11):1500-1502.

2. Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493-505.

3. Sterne JA, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009;373(9672):1352-1363.

4. Cain LE, et al. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med 2011;154(8):509-515.

5. Kitahata MM, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009;360(18):1815-1826.

6. Giordano TP, et al. The population effectiveness of highly active antiretroviral therapy: are good drugs good enough? Curr HIV/AIDS Rep 2005;2(4):177-183.

7. Metsch LR, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008;47(4):577-584.

8. Thompson MA, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012;308(4):387-402.

9. Tripathi A, et al. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses 2011;27(7):751-758.

10. U.S. Department of Health and Human Services. Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners. Findings result from NIH-funded international study. NIH News 2011. http://www.nih.gov/news/health/may2011/niaid-12.htm. Accessed May 17, 2011.

11. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1–infected adults and adolescents. 2013. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0. Accessed April 8, 2014.

12. Ulett KB, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS 2009;23(1):41-49.

13. Vernazza PL, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000;14(2):117-121.

14. Walensky RP, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194(1):11-19.

15. Morton L, et al. (Reporting Participation in Epidemiologic Studies: A Survey of Practice. Am. J. Epidemiol. 2006; 163(3): 197-203.

16. Mathematica Policy Research. Declining Response Rates in Federal Surveys: Trends and Implications. 2016. https://aspe.hhs.gov/system/files/pdf/255531/Decliningresponserates.pdf

17. Abdelazeem B, et al. Does usage of monetary incentive impact the involvement in surveys? A systematic review and meta-analysis of 46 randomized controlled trials. PLoS One. 2023; Jan 17;18(1).

18. Edwards PJ, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009; Jul 8;2009(3).

19. Edwards P, et al. Increasing response rates to postal questionnaires: systematic review BMJ 2002;324:1183.

20. Brueton VC, Tierney JF, Stenning S, Meredith S, Harding S, Nazareth I, Rait G. Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis. BMJ Open. 2014; Feb 4;4(2).

21. Groves R. (2006). Nonresponse Rates and Nonresponse Bias in Household Surveys. Public Opinion Quarterly, 2006; 70(5): 646–675.